Literature DB >> 16460799

PGE(2) receptor subtype functionality on immature forms of human leukemic blasts.

Emilie Malissein1, Stéphane Reynaud, Dominique Bordessoule, Jean Luc Faucher, Pascal Turlure, Franck Trimoreau, Yves Denizot.   

Abstract

The ability of prostaglandin E2 (PGE2) to regulate the immune system is well documented. PGE2 effects are mediated through interactions with four distinct membrane EP receptors (EP(1-4)). We investigated, for the first time, the functionality of EP receptors on immature forms of blast cells of acute myeloid leukemic (AML) and acute lymphoid leukemic (ALL) patients. RT-PCR experiments documented the presence of the four EP receptor subtype transcripts in leukemic blasts of AML M0, AML M1, AML M2 and ALL patients. Western blot analysis only documented the presence of the EP2 receptor. Functional assays (cAMP production, calcium flux) confirmed Western blot results, i.e., the presence of functional EP2 receptors. Results of the present study suggest that the mechanism used by PGE2 to influence blast physiology is mediated through the EP2 receptor subtype, and subsequently through a cAMP-elevating effect. Results obtained with M0-2 subtypes have to be necessarily extended to more differentiated phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460799     DOI: 10.1016/j.leukres.2005.12.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  mPGES-1 in leukemic cells of AML patients.

Authors:  Pauline Rouaud; Estelle Guerin; Dominique Bordessoule; Pascal Turlure; Franck Trimoreau; Yves Denizot
Journal:  Int J Hematol       Date:  2012-01-07       Impact factor: 2.490

Review 2.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

3.  Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

Authors:  Nina Richartz; Eva Duthil; Anthony Ford; Elin Hallan Naderi; Sampada Bhagwat; Karin M Gilljam; Marta Maria Burman; Ellen Ruud; Heidi Kiil Blomhoff; Seham Skah
Journal:  Blood Adv       Date:  2019-11-12

4.  Lipid mediators and human leukemic blasts.

Authors:  Rémi Fiancette; Christelle Vincent-Fabert; Estelle Guerin; Franck Trimoreau; Yves Denizot
Journal:  J Oncol       Date:  2010-10-10       Impact factor: 4.375

5.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

6.  Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.

Authors:  Elin Hallan Naderi; Seham Skah; Hege Ugland; Ola Myklebost; Dagny Lise Sandnes; Maria Lyngaas Torgersen; Dag Josefsen; Ellen Ruud; Soheil Naderi; Heidi Kiil Blomhoff
Journal:  Mol Cancer       Date:  2015-01-27       Impact factor: 27.401

7.  De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.

Authors:  Matheus Rodrigues Lopes; João Kleber Novais Pereira; Paula de Melo Campos; João Agostinho Machado-Neto; Fabiola Traina; Sara T Olalla Saad; Patricia Favaro
Journal:  Sci Rep       Date:  2017-01-13       Impact factor: 4.379

8.  PGE1-Containing Protocols Generate Mature (Leukemia-Derived) Dendritic Cells Directly from Leukemic Whole Blood.

Authors:  Daniel Christoph Amberger; Fatemeh Doraneh-Gard; Carina Gunsilius; Melanie Weinmann; Sabine Möbius; Christoph Kugler; Nicole Rogers; Corinna Böck; Uwe Ködel; Jan-Ole Werner; Doris Krämer; Britta Eiz-Vesper; Andreas Rank; Christoph Schmid; Helga Maria Schmetzer
Journal:  Int J Mol Sci       Date:  2019-09-17       Impact factor: 5.923

9.  cAMP-mediated autophagy inhibits DNA damage-induced death of leukemia cells independent of p53.

Authors:  Seham Skah; Nina Richartz; Eva Duthil; Karin M Gilljam; Christian Bindesbøll; Elin Hallan Naderi; Agnete B Eriksen; Ellen Ruud; Marta M Dirdal; Anne Simonsen; Heidi Kiil Blomhoff
Journal:  Oncotarget       Date:  2018-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.